This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit July 30, 2014


 

Advertisement

Prostate cancer patients face higher risk of second malignancies
Renal & Urology News
Prostate cancer (PCa) patients are at increased risk for secondary primary malignancies compared with the general population, a study found. In this study of 20,558 PCa patients in Zurich, Switzerland, 1,718 developed a second primary tumor after their PCa diagnosis, most frequently lung and colon cancer (15 percent and 13 percent, respectively).
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Study helps compare risks of treatments for early esophageal cancer
Medical Xpress
A new study, published in the July 2014 issue of the Journal of the National Cancer Institute by Northwestern Medicine researchers, sheds new light on the risks associated with the growing popularity of endoscopic resection in the treatment of localized, early-stage esophageal cancer. Researchers found that the more traditional surgical resection, while more invasive, provided significantly better outcomes (an 87.6 percent five-year survival rate compared with a 76 percent five-year survival rate for patients who had endoscopic resection).
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
SPONSORED CONTENT


HPV test vs. the Pap smear: Which detects cancer better?
TIME
When it comes to detecting cervical cancer, the Pap test has been the gold standard for more than 60 years. But as the role of human papillomavirus virus (HPV) in contributing to the cancer has emerged in recent years, screening for HPV has started to rival the Pap. A recent study of more than 1 million women added to the HPV test’s utility; it found that the HPV test was more successful in assessing cervical cancer risk than the Pap smear.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


2014 Commission on Cancer Annual Update notification
Commission on Cancer
All Commission on Cancer (CoC)-accredited programs scheduled for survey during 2015-2016 should note that the Program Activity Record (PAR) Annual Update period will run from July 1 to September 30, 2014. In order to maintain your CoC accreditation, your program must complete this activity within the specified timeframe. No extensions will be granted. Questions about the PAR or Annual Update should be e-mailed to SAR@facs.org. Questions regarding your CoC Datalinks user ID and password should be e-mailed to CoCdatalinks@facs.org.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
PRODUCT SHOWCASE
  Nav Certification: New Jersey, Indiana & California
Click here for a NCBC-sponsored navigation certification program coming near you! Enhance your programs by certifying volunteers/lay support staff as well as licensed professionals. Do not miss out on improving the cornerstone of excellence in breast care--navigation!
  • Morristown New Jersey - Navigation Certification: IM A CPN
  • Southern Indiana - Time to get certified
  • Regional Application Form
  •  


    Federal cervical cancer screening program saves lives
    Medscape
    The National Breast and Cervical Cancer Early Detection Program (NBCCEDP), a cervical cancer screening program targeted to poor and medically underserved women, has reduced cancer-related deaths and improved quality of life, investigators say. From 1991 through 2007, 1.8 million women were screened under the NBCCEDP, report Donatus U. Ekwueme, PhD, from the Division of Cancer Prevention and Control at the Centers for Disease Control and Prevention in Atlanta, Georgia, and colleagues.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Role of adjuvant radiation therapy in melanoma
    OncLive
    Adjuvant radiation therapy reduces the risk of local recurrence in patients with high-risk melanoma, notes Robert H. I. Andtbacka, MD, CM. However, this benefit does not translate into an extension in overall survival or control of distant recurrences. Additionally, Andtbacka notes, radiation therapy is accompanied by increased locoregional symptoms, with areas of the head and neck being less impacted compared with the groin.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Colorectal cancer survival associated with higher vitamin D levels
    Oncology Nurse Advisor
    Colorectal cancer patients with high levels of vitamin D in their blood are more likely to survive the disease, a study shows. Patients with the highest levels of vitamin D have half the risk of dying compared with those with the lowest levels. The study is the first to correlate total blood levels of vitamin D (both produced from exposure to sunlight and obtained from dietary sources) in colorectal cancer patients after their diagnosis with their long-term survival prospects.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Accreditation 101 — Learning the Basics of CoC Accreditation and Standards
    Commission on Cancer
    Plan now to attend Accreditation 101 — Learning the Basics of CoC Accreditation and Standards in San Antonio, Texas, on Friday, September 12, 2014. The program agenda will provide information on how to meet the standards and prepare for your accreditation survey. Review the program brochure and see for yourself why the February program sold out! Register today, and do not forget to make your hotel reservation while space is still available.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Targeted virus could boost chemo's effects for arm and leg cancer
    Medical News Today
    As an alternative to amputation, patients with arm or leg cancer can undergo isolated limb perfusion chemotherapy, which is given directly to blood vessels that supply the affected arm or leg. The technique allows high-dose chemotherapy drugs to target the affected limb without blasting the body with toxic chemicals. To do this, a heart and lung bypass machine is connected to the arm or leg to separate its blood supply from the rest of the body.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Genetics is the dominant risk factor for familial breast, prostate, and colorectal cancers
    Oncology Nurse Advisor
    A study of people who were adopted identified genetics as the dominant risk factor in familial breast, prostate, and colorectal cancers. These new findings are based on studies of population registries by researchers at the Centre for Primary Health Care Research at Lund University and Region Skåne in Sweden. "The results of our study do not mean that [a person's] lifestyle is not important for the individual's risk of developing cancer, but it suggests that the risk for the three most common types of cancer is dependent to a greater extent on genetics," said Bengt Zöller, MD, PhD, a reader at Lund University who led the study.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Adjuvant radiation therapy improved survival in diffuse-type gastric cancer
    Healio
    Patients with diffuse-type gastric cancer demonstrated prolonged OS when they received adjuvant radiation therapy, according to results of a SEER analysis. Alexander M. Stessin, MD, PhD, of the department of radiation oncology at Weill Cornell Medical College, and colleagues used the 2002 to 2005 SEER database to identify 1,889 patients with newly diagnosed diffuse-type gastric cancer who underwent surgical resection. Of these patients, 782 received adjuvant radiation therapy and 1,107 did not.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    TRENDING ARTICLES
    Missed last week's issue? See which articles your colleagues read most.

        Novel genomic changes identified in most common form of lung cancer (Oncology Nurse Advisor)
    Removing both breasts may not improve survival from breast cancer (TIME)
    Free webinar on cancer pathology reporting using the eCC to help you meet CoC Standard 2.1 (CoC)
    2014 Commission on Cancer Annual Update notification (Commission on Cancer)
    Some with prostate cancer may not get best advice (HealthDay News via Web MD)

    Don't be left behind. Click here to see what else you missed.
     
    Advertisement



    The CoC Brief

    Colby Horton, Vice President of Publishing, 469.420.2601
    Download media kit

    Samantha Emerson, Content Editor, 469.420.2669
    Contribute news

    Disclaimer: The CoC Brief is a digest of the most important news selected for the American College of Surgeons Commission on Cancer from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Commission on Cancer does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons and the Commission on Cancer.


    Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

    This edition of The CoC Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

    Recent issues

    July 23, 2014
    July 23, 2014
    July 16, 2014
    July 9, 2014






    7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063